| scholarly article | Q13442814 |
| P2093 | author name string | Shiuh-Wen Luoh | |
| Tao Bai | |||
| P433 | issue | 3 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 473-479 | |
| P577 | publication date | 2007-10-04 | |
| P1433 | published in | Carcinogenesis | Q326022 |
| P1476 | title | GRB-7 facilitates HER-2/Neu-mediated signal transduction and tumor formation | |
| P478 | volume | 29 |
| Q30496002 | A gene on the HER2 amplicon, C35, is an oncogene in breast cancer whose actions are prevented by inhibition of Syk |
| Q39030506 | Context-dependent role of Grb7 in HER2+ve and triple-negative breast cancer cell lines |
| Q44853520 | Design and testing of bicyclic inhibitors of Grb7--are two cycles better than one? |
| Q36758884 | Dissecting GRB7-mediated signals for proliferation and migration in HER2 overexpressing breast tumor cells: GTP-ase rules |
| Q34121550 | EGF-induced Grb7 recruits and promotes Ras activity essential for the tumorigenicity of Sk-Br3 breast cancer cells |
| Q90266694 | Epigenetically altered miR‑193a‑3p promotes HER2 positive breast cancer aggressiveness by targeting GRB7 |
| Q42834890 | Expression screening of 17q12-21 amplicon reveals GRB7 as an ERBB2-dependent oncogene |
| Q64913584 | GRB7 dependent proliferation of basal-like, HER-2 positive human breast cancer cell lines is mediated in part by HER-1 signaling. |
| Q39456781 | GRB7 is required for triple-negative breast cancer cell invasion and survival |
| Q53464299 | GRB7 protein over-expression and clinical outcome in breast cancer. |
| Q33713239 | Genome profiling of ERBB2-amplified breast cancers |
| Q36261762 | Grb7 gene amplification and protein expression by FISH and IHC in ovarian cancer |
| Q33528957 | Grb7 upregulation is a molecular adaptation to HER2 signaling inhibition due to removal of Akt-mediated gene repression |
| Q64972691 | Grb7, a Critical Mediator of EGFR/ErbB Signaling, in Cancer Development and as a Potential Therapeutic Target. |
| Q33676758 | Growth factor receptor-bound protein-7 (Grb7) as a prognostic marker and therapeutic target in breast cancer |
| Q37216946 | HER-2 gene amplification in human breast cancer without concurrent HER-2 over-expression |
| Q34048024 | High-resolution genomic and expression analyses of copy number alterations in HER2-amplified breast cancer |
| Q42103874 | Insight into the Selectivity of the G7-18NATE Inhibitor Peptide for the Grb7-SH2 Domain Target |
| Q38402575 | Integrated Proteomic and Genomic Analysis of Gastric Cancer Patient Tissues |
| Q39418443 | Interaction of the non-phosphorylated peptide G7-18NATE with Grb7-SH2 domain requires phosphate for enhanced affinity and specificity |
| Q34581878 | Progress towards the development of SH2 domain inhibitors |
| Q36914607 | Rational design of novel N-alkyl-N capped biostable RNA nanostructures for efficient long-term inhibition of gene expression |
| Q37528144 | Regularized Multivariate Regression for Identifying Master Predictors with Application to Integrative Genomics Study of Breast Cancer |
| Q47117237 | Shortened Penetratin Cell-Penetrating Peptide Is Insufficient for Cytosolic Delivery of a Grb7 Targeting Peptide |
| Q47377334 | Src homology 2 domains enhance tyrosine phosphorylation in vivo by protecting binding sites in their target proteins from dephosphorylation. |
| Q28484496 | Targeting GRB7/ERK/FOXM1 signaling pathway impairs aggressiveness of ovarian cancer cells |
| Q39203618 | The discovery of phenylbenzamide derivatives as Grb7-based antitumor agents |
| Q38279378 | The insulin resistance Grb14 adaptor protein promotes thyroid cancer ret signaling and progression |
| Q37339045 | Tyrosine phosphorylation of growth factor receptor-bound protein-7 by focal adhesion kinase in the regulation of cell migration, proliferation, and tumorigenesis |
| Q36964946 | Unexpected involvement of staple leads to redesign of selective bicyclic peptide inhibitor of Grb7. |
| Q38962113 | Validation of analytical breast cancer microarray analysis in medical laboratory. |
Search more.